相关实验视频

Updated: Jul 9, 2025

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.4K

案例报告:CD19和CD20单克隆抗体与儿童耐火性急性B型淋巴细胞白血病的顺序化疗

Jia-Nan Li1, Yu Li1, Ji-Xun Lin1

  • 1Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Frontiers in immunology
|December 4, 2023
PubMed
概括

用CD19和CD20单克隆抗体进行化疗有效清除儿科B-ALL的最小残留疾病,使移植成为可能. 这种组合疗法耐受性很好,对耐火病例显示出有前途.

关键词:
其他血液造血干细胞移植.这就是Blinatumomabomab.最少残留疾病的最小残留疾病.耐火性急性B型淋巴细胞白血病这就是Rituximab.

更多相关视频

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.1K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.4K

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K